| Literature DB >> 26208966 |
Mohd Ishtikhar1, Anam Khan2, Chih-Kai Chang3, Lilian Tsai-Wei Lin3, Steven S-S Wang3, Rizwan Hasan Khan1.
Abstract
6-thioguanine (6-TG) is an antineoplastic, nucleobase guanine, purine analog drug belongs to thiopurine drug-family of antimetabolites. In the present study, we report an experimental approach towards interaction mechanism of 6-TG with human serum albumin (HSA) and examine the chemical stability of HSA in the presence of denaturants such as guanidine hydrochloride (GdnHCl) and urea. Interaction of 6-TG with HSA has been studied by various spectroscopic and spectropolarimeteric methods to investigate what short of binding occurs at physiological conditions. 6-TG binds in the hydrophobic cavity of subdomain IIA of HSA by static quenching mechanism which induces conformation alteration in the protein structure. That helpful for further study of denaturation process where change in secondary structures causes unfolding of protein that also responsible for severance of domain III from rest of the protein part. We have also performed molecular simulation and molecular docking study in the presence of denaturating agents to determine the binding property of 6-TG and the effect of denaturating agents on the structural activity of HSA. We had found that GdnHCl is more effective denaturating agent when compared to urea. Hence, this study provides straight evidence of the binding mechanism of 6-TG with HSA and the formation of intermediate or unfolding transition that causes unfolding of HSA.Entities:
Keywords: 6-thioguanine; circular dichroism; fluorescence spectroscopy; guanidine hydrochloride denaturation; human serum albumin; molecular dynamics; urea denaturation
Mesh:
Substances:
Year: 2016 PMID: 26208966 DOI: 10.1080/07391102.2015.1054433
Source DB: PubMed Journal: J Biomol Struct Dyn ISSN: 0739-1102